APA (7th ed.) Citation

R, P., FC, Q., J, H., S, E., C, T., WM, v. d. F., . . . O, H. (2025). How can Alzheimer's disease blood-based biomarkers reach clinical practice? Alzheimer's & dementia (Amsterdam, Netherlands), 17(4), e70207. https://doi.org/10.1002/dad2.70207

Chicago Style (17th ed.) Citation

R, Perneczky, et al. "How Can Alzheimer's Disease Blood-based Biomarkers Reach Clinical Practice?" Alzheimer's & Dementia (Amsterdam, Netherlands) 17, no. 4 (2025): e70207. https://doi.org/10.1002/dad2.70207.

MLA (9th ed.) Citation

R, Perneczky, et al. "How Can Alzheimer's Disease Blood-based Biomarkers Reach Clinical Practice?" Alzheimer's & Dementia (Amsterdam, Netherlands), vol. 17, no. 4, 2025, p. e70207, https://doi.org/10.1002/dad2.70207.